Last reviewed · How we verify
NCT06818201
Effects of tDCS on Motor Cortex During ACL Recovery
NA trial testing NIBS in Anterior Cruciate Ligament Reconstruction Rehabilitation in 54 participants. Currently enrolling.
27 December 2027
Quick facts
| Lead sponsor | Fundación Universidad Católica de Valencia San Vicente Mártir |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 54 |
| Start date | 28 November 2025 |
| Primary completion | 27 December 2027 |
| Estimated completion | 27 December 2027 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- NIBS
- Rehabilitation
- Sham Comparator
Conditions studied
- Anterior Cruciate Ligament Reconstruction Rehabilitation — all drugs for Anterior Cruciate Ligament Reconstruction Rehabilitation →
Sponsor
Fundación Universidad Católica de Valencia San Vicente Mártir — full company profile →
Who can join
Adults 16 to 40, any sex, with Anterior Cruciate Ligament Reconstruction Rehabilitation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Anterior Cruciate Ligament (ACL) is a prevalent injury, particularly among young and physically active individuals. The efficacy of transcranial direct current stimulation (tDCS) and exercise-based rehabilitation on neuromuscular control in post-ACL reconstruction patients is evaluated, and these techniques are combined.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Enhancing functional recovery after ACL injury. A protocol for a randomized control trial of transcranial direct current stimulation over the motor cortex.
Vicente-Mampel J, López-Soler J, Sevilla-López P, Ferrer-Torregrosa J, et al · · 2025 · PMID 41180415 · DOI 10.3389/fresc.2025.1627228
Verify or expand the search:
- PubMed search for NCT06818201
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NIBS
Trials testing the same drug.
- NCT07486323 — Combined Non-Invasive Brain and Visual Stimulation for Vision Improvement · NA · not yet recruiting
Other recruiting trials for Anterior Cruciate Ligament Reconstruction Rehabilitation
Currently open trials in the same condition.
- NCT07523854 — Effect of Graft Type on Knee Muscle Strength After ACL Reconstruction · recruiting
- NCT07058467 — Anterior Cruciate Ligaments: Studying Updates in neuroCognition After Knee Manipulation · NA · recruiting
- NCT07128602 — Determining the Effects of Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function After ACL Reconstruction · Phase 1, PHASE2 · recruiting
- NCT06973642 — Evaluation of Home-based Telerehabilitation Platform to Augment Orthopedic Rehabilitation · NA · recruiting
- NCT06991192 — ACL Reconstruction Rehabilitation With Exercise and Psychological Support · NA · recruiting
Other Fundación Universidad Católica de Valencia San Vicente Mártir trials
Trials by the same sponsor.
- NCT07282236 — Retrospective Comparative Outcomes of Gamma and InterTAN Nail for Unstable Intertrochanteric Hip Fractures · completed
- NCT06932406 — Orofacial Pain Self-management: Personality Moderation Effect · NA · recruiting
- NCT06969456 — Managing Chronic Spinal Pain With Exercise and Neuromodulation · NA · recruiting
- NCT07004543 — Evaluation of Toe Separators in Foot Health · NA · completed
- NCT06783374 — Effect of Neuromodulation and Therapeutic Exercise in Urinary Incontinence · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06818201 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundación Universidad Católica de Valencia San Vicente Mártir
- Last refreshed: 2 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06818201.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing